Crossmark

COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments

Published Online: 2020-05-15

Published Print: 2020-07

Authors

,

Zolk, Oliver http://orcid.org/0000-0002-8220-3834
Hafner, Susanne

Schmidt, Christoph Q.
Funding

Funding for this research was provided by:

Medizinische Hochschule Brandenburg CAMPUS gGmbH
License Information

Text and Data Mining valid from 2020-05-15

Version of Record valid from 2020-05-15
More Information

Article History

Received: 15 April 2020

Accepted: 28 April 2020

First Online: 15 May 2020

Document is current